Best for
Mobile

Cardinal Health, Inc (CAH) is a leading medical distribution business based in the US. Cardinal Health is listed on the NYSE and employs 48,000 staff. All prices are listed in US Dollars.
Best for
Mobile
Best for
Low-cost
Best for
All rounder
Best for
Beginners
52-week range | $39.4056 - $58.6524 |
---|---|
50-day moving average | $54.7667 |
200-day moving average | $51.9484 |
Wall St. target price | $62.5 |
PE ratio | 16.6386 |
Dividend yield | $1.94 (3.51%) |
Earnings per share (TTM) | $3.329 |
Other fees may apply. Your capital is at risk.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Cardinal Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cardinal Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cardinal Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Cardinal Health shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Cardinal Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.9319. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cardinal Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Cardinal Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $2.7 billion.
The EBITDA is a measure of a Cardinal Health's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $154.6 billion |
---|---|
Operating margin TTM | 1.16% |
Gross profit TTM | $6.9 billion |
Return on assets TTM | 2.78% |
Return on equity TTM | 83.76% |
Profit margin | 0.63% |
Book value | $4.837 |
Market capitalisation | $16.3 billion |
TTM: trailing 12 months
There are currently 3.0 million Cardinal Health shares held short by investors – that's known as Cardinal Health's "short interest". This figure is 34.9% down from 4.6 million last month.
There are a few different ways that this level of interest in shorting Cardinal Health shares can be evaluated.
Cardinal Health's "short interest ratio" (SIR) is the quantity of Cardinal Health shares currently shorted divided by the average quantity of Cardinal Health shares traded daily (recently around 1.9 million). Cardinal Health's SIR currently stands at 1.55. In other words for every 100,000 Cardinal Health shares traded daily on the market, roughly 1550 shares are currently held short.
However Cardinal Health's short interest can also be evaluated against the total number of Cardinal Health shares, or, against the total number of tradable Cardinal Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cardinal Health's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Cardinal Health shares in existence, roughly 10 shares are currently held short) or 0.0117% of the tradable shares (for every 100,000 tradable Cardinal Health shares, roughly 12 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cardinal Health.
Find out more about how you can short Cardinal Health stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Cardinal Health.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 12.66
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Cardinal Health's overall score of 12.66 (as at 01/01/2019) is excellent – landing it in it in the 6th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Cardinal Health is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 0.25/100
Social score: 5.84/100
Governance score: 1.08/100
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Cardinal Health scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Cardinal Health hasn't always managed to keep its nose clean.
Cardinal Health, Inc was last rated for ESG on: 2019-01-01.
Total ESG score | 12.66 |
---|---|
Total ESG percentile | 6.34 |
Environmental score | 0.25 |
Social score | 5.84 |
Governance score | 1.08 |
Level of controversy | 3 |
Dividend payout ratio: 34.07% of net profits
Recently Cardinal Health has paid out, on average, around 34.07% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.51% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Cardinal Health shareholders could enjoy a 3.51% return on their shares, in the form of dividend payments. In Cardinal Health's case, that would currently equate to about $1.94 per share.
While Cardinal Health's payout ratio might seem fairly standard, it's worth remembering that Cardinal Health may be investing much of the rest of its net profits in future growth.
Cardinal Health's most recent dividend payout was on 15 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 31 December 2020 (the "ex-dividend date").
Cardinal Health's shares were split on a 3:2 basis on 23 April 2001. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Cardinal Health shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Cardinal Health shares which in turn could have impacted Cardinal Health's share price.
Over the last 12 months, Cardinal Health's shares have ranged in value from as little as $39.4056 up to $58.6524. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Cardinal Health's is 1.0478. This would suggest that Cardinal Health's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Subscribe to trending stock alerts for a chance to win
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company operates through two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. It also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; and offers pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers. In addition, this segment repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products. It also provides incontinence, nutritional delivery, wound care, cardiovascular, and endovascular products; single-use surgical drapes, gowns and apparel, and fluid suction and collection systems; urology products; operating room supplies; and electrode products. In addition, this segment distributes a range of national brand products, including medical, surgical, and laboratory products; and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.